{{Rsnum
|rsid=7600259
|Chromosome=2
|position=34868226
|Orientation=plus
|GMAF=0.1139
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 0.0 | 23.2 | 76.8
| HCB | 2.9 | 21.9 | 75.2
| JPT | 0.9 | 12.4 | 86.7
| YRI | 2.7 | 25.2 | 72.1
| ASW | 0.0 | 21.1 | 78.9
| CHB | 2.9 | 21.9 | 75.2
| CHD | 0.9 | 20.2 | 78.9
| GIH | 4.0 | 20.0 | 76.0
| LWK | 1.8 | 31.8 | 66.4
| MEX | 1.8 | 0.0 | 98.2
| MKK | 1.9 | 31.4 | 66.7
| TSI | 1.0 | 14.9 | 84.2
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=22952603
  |Trait=Response to amphetamines
  |Title=Genome-wide association study of d-amphetamine response in healthy volunteers identifies putative associations, including cadherin 13 (CDH13).
  |RiskAllele=
  |Pval=1E-6
  |OR=NR
  |ORtxt=NR
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}